N

Ngl Fine Chem Ltd
NSE:NGLFINE

Watchlist Manager
Ngl Fine Chem Ltd
NSE:NGLFINE
Watchlist
Price: 1 424.7 INR 1.18%
Market Cap: 8.8B INR

Gross Margin
Ngl Fine Chem Ltd

51%
Current
43%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51%
=
Gross Profit
1.9B
/
Revenue
3.8B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
IN
Ngl Fine Chem Ltd
NSE:NGLFINE
8.8B INR
51%
US
Eli Lilly and Co
NYSE:LLY
985.1B USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
491.6B USD
68%
CH
Roche Holding AG
SIX:ROG
259.2B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
207.5B GBP
82%
US
Merck & Co Inc
NYSE:MRK
267.2B USD
79%
CH
Novartis AG
SIX:NOVN
208.2B CHF
76%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
82%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
68%
US
Pfizer Inc
NYSE:PFE
143.1B USD
75%
No Stocks Found

Ngl Fine Chem Ltd
Glance View

Market Cap
8.8B INR
Industry
Pharmaceuticals

NGL Fine-Chem Ltd. manufactures pharmaceuticals and intermediates for usage in veterinary and human health. The company is headquartered in Mumbai, Maharashtra and currently employs 329 full-time employees. The firm manufactures active pharmaceutical ingredients and finished formulations. Its products include APIs Animal Health, APIs Human Health, Intermediates and Finished Dosage Forms. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, Diminazene Diaceturate and Decoquinate, among others. The APIs Human Health products include Nitazoxanide, Atovaquone and Ranolazine. The Intermediates products include 2-Chloro-N-(2,6-dimethylphenyl)acetamide, N-(2,6-Dimethylphenyl)-1-Piperazineacetamide and 2-[(2-methoxyphenoxy)methy]oxirane. The Finished dosage form products include Diminazene Aceturate Granules and Homidium Chloride Tablets.

NGLFINE Intrinsic Value
1 241.77 INR
Overvaluation 13%
Intrinsic Value
Price
N
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51%
=
Gross Profit
1.9B
/
Revenue
3.8B
What is the Gross Margin of Ngl Fine Chem Ltd?

Based on Ngl Fine Chem Ltd's most recent financial statements, the company has Gross Margin of 51%.

Back to Top